| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 641 |
| 1 | DUPILUMAB | 562 |
| 2 | PREDNISONE | 424 |
| 3 | ETANERCEPT | 405 |
| 4 | METHOTREXATE SODIUM | 387 |
| 5 | METHOTREXATE | 345 |
| 6 | SECUKINUMAB | 268 |
| 7 | ASPIRIN | 243 |
| 8 | ERGOCALCIFEROL | 242 |
| 9 | ASPIRIN 325 MG | 230 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE | 66 | 0.0120 |
| 1 | APOMORPHINE HYDROCHLORIDE | 19 | 0.0112 |
| 2 | INFLIXIMAB-DYYB | 31 | 0.0090 |
| 3 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 9 | 0.0087 |
| 4 | ERGOCALCIFEROL | 242 | 0.0081 |
| 5 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | 3 | 0.0067 |
| 6 | VEMURAFENIB | 77 | 0.0064 |
| 7 | PSYLLIUM HUSK | 8 | 0.0059 |
| 8 | PENICILLIN G POTASSIUM | 4 | 0.0055 |
| 9 | OMADACYCLINE | 9 | 0.0052 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 871 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 619 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 562 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 559 |
| 4 | Kinase Inhibitor [EPC] | 423 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 346 |
| 6 | Interleukin-17A Antagonist [EPC] | 284 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 246 |
| 8 | Provitamin D2 Compound [EPC] | 242 |
| 9 | Vitamin C [EPC] | 239 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 1 | Amino Acid Hypertonic Solution [EPC] | 2 | 0.0127 |
| 2 | Provitamin D2 Compound [EPC] | 242 | 0.0081 |
| 3 | Interleukin-17A Antagonist [EPC] | 284 | 0.0076 |
| 4 | Adrenocorticotropic Hormone [EPC] | 4 | 0.0045 |
| 5 | Monoamine Oxidase Inhibitor [EPC] | 11 | 0.0036 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 8 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 9 | Human Immunoglobulin G [EPC] | 69 | 0.0033 |